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Dear Editors, 
  
Opening statement / abstract:  
Lin et al.1 report novel insights into the biology of the phenomenon with which 
paediatric ophthalmologists battle, ie lens regeneration after cataract surgery in 
infants. They then take the interesting approach of considering whether, using a 
different surgical technique, it is possible to convert this ‘post-operative complication’ 
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into an alternative therapy for children aged under 24 months old.1 However, the 
early outcomes reported for the experimental group fall far short of expected 
outcomes for this population, ie young children with uncomplicated bilateral 
congenital cataract, for which the authors offer no comment or explanation.  
 
Regeneration of residual lens cells following surgical removal of congenital cataract 
can result in reopacification, which needs to be treated by further intraocular surgery, 
necessitating repeated general anaesthetics during a sensitive period of 
neurodevelopment.  Lin et al’s1 elegant adaptation of this regenerative process, in 
which a novel ‘surgical method of cataract removal preserves endogenous lens cells, 
achieving functional lens regeneration’1 may eventually lead to the development of 
treatments for degenerative disease. However, their report conflates adult cataract (a 
degenerative process) and congenital and infantile cataract in relation to a number of 
key issues and resulted in a similar unhelpful conflation in the media coverage of this 
paper.2 Cataract is virtually universal in older age, making cataract surgery one of 
the most common surgical procedures and with enviably excellent visual outcomes. 
By contrast, infantile cataract is uncommon, affecting 3-15 per 10,0000 children 
worldwide.3 We now understand that mutations within the genes responsible for the 
production or orchestration of the lens epithelial progenitor / stem cells (LECs) are 
responsible for the majority of bilateral congenital or infantile cataract, even in cases 
where there is no family history.4 Thus the treatment approach adapted by Lin et al, 
which relies on regeneration of  lens stem cells without addressing the underlying 
genetic defect, cannot be definitive. Children treated using this technique may 
require further surgery but Lin et al do not acknowledge this in the article.  
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The rationale for the trial reported by Lin et al is the need to address adverse 
outcomes associated with using artificial intraocular lenses but this was not the 
‘control’ standard approach evaluated within the report. Equivalence in vision 
outcomes between their intervention and control groups was reported, but these 
should have been assessed against the extant benchmark. Outcomes in infantile 
cataract have improved substantially over the past few decades, largely due to 
application of basic neuroscientific understanding of sensitive and critical periods in 
visual neurodevelopment. Hence whole population newborn screening programmes 
exist in many countries to ensure early diagnosis and prompt referral for specialist 
treatment. Younger age at surgery is the most powerful predictor of better visual 
outcome and the ‘window for intervention’ in cataract truly present at birth is 
conventionally considered the first six to eight weeks of life. Late diagnosis/treatment 
is the key factor in poor visual outcomes due to irreversible amblyopia, as particularly 
evidence in settings without resource or infrastructure for screening and early 
specialist intervention. We have previously, on behalf of the British Isles Congenital 
Cataract Interest Group, reported outcomes within a contemporaneous, nationally 
representative cohort of children undergoing surgery in the British Isles for congenital 
and infantile cataract in the first two years of life (IoLunder2 study).5 Our outcomes 
are comparable to other contemporary reports,6 and represents a greater than 2-fold 
better outcome than that reported by Lin et al in either their experimental or control 
groups. Indeed, the mean acuity achieved in their trial is the threshold for legal 
definition of blindness, an outcome that would lead most ophthalmologists, and likely 
most parents, to question the value of this new proposed intervention. 
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Cataract related childhood visual impairment is largely due to bilateral deprivation 
amblyopia, the failure to restore a normal trajectory of visual neurodevelopment 
during a brief and finite window of opportunity. This critical window closes in the first 
six months of life. Thereafter, ‘successful’ treatment stands little chance of good 
outcome.  
 
Effective treatment for congenital cataract requires, alongside surgery, post-
operative management of the impact of the absence of the focusing power of the 
natural crystalline lens. Failure to appropriately manage the refractive (focusing) 
state of the post-surgical eye will result in a dense amblyopia. As the method 
described in Lin et al involves an 8 month post-operative period of partially obscured 
and poorly focused vision (as the lens regenerates) the inevitable resultant 
amblyopia may explain the poor visual outcomes, as the authors offer no other 
explanation, nor described how the rapidly changing and high refractive error (18 
Diopters in 8 months) was managed. Had the report adhered to international 
standard of CONSORT7 it might be have been possible to assess its quality (internal 
validity) and generalisability (external validity). For example, it is necessary to know 
a) whether the control and intervention groups were equivalent with respect to 
baseline clinical characteristics (particularly age at surgery), b) how randomization 
was undertaken, c) the power calculation and the primary outcome and secondary 
outcomes on which this was based, c) how clustering by surgeon was addressed 
and d) how clustering/correlation of outcomes data was addressed in the analysis, 
given that both eyes of each subject were treated and analysed.  The authors have 
described their study as a Phase 1 trial, but the aim of such investigation is to assess 
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adverse outcomes of treatment, such as uncorrected high or irregular refractive 
outcome, which is amblyogenic.  
 
As the paper stands, it is not possible to agree with its principal conclusion that it 
provides evidence ‘supporting the superiority of the novel treatment’. A tempered 
report, clearly articulating the limitations of the approach with respect to outcome and 
permanency of effect, would have avoided giving the false impression that their 
approach can be expected to supercede current treatment practices.  
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